1. Home
  2. XOMA vs WENN Comparison

XOMA vs WENN Comparison

Compare XOMA & WENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • WENN
  • Stock Information
  • Founded
  • XOMA 1981
  • WENN 2025
  • Country
  • XOMA United States
  • WENN United States
  • Employees
  • XOMA N/A
  • WENN N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • WENN
  • Sector
  • XOMA Health Care
  • WENN
  • Exchange
  • XOMA Nasdaq
  • WENN Nasdaq
  • Market Cap
  • XOMA 457.6M
  • WENN 387.6M
  • IPO Year
  • XOMA N/A
  • WENN 2025
  • Fundamental
  • Price
  • XOMA $34.88
  • WENN $10.30
  • Analyst Decision
  • XOMA Strong Buy
  • WENN
  • Analyst Count
  • XOMA 2
  • WENN 0
  • Target Price
  • XOMA $69.50
  • WENN N/A
  • AVG Volume (30 Days)
  • XOMA 52.1K
  • WENN 44.4K
  • Earning Date
  • XOMA 11-06-2025
  • WENN 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • WENN N/A
  • EPS Growth
  • XOMA N/A
  • WENN N/A
  • EPS
  • XOMA N/A
  • WENN N/A
  • Revenue
  • XOMA $44,952,000.00
  • WENN N/A
  • Revenue This Year
  • XOMA $88.91
  • WENN N/A
  • Revenue Next Year
  • XOMA $13.80
  • WENN N/A
  • P/E Ratio
  • XOMA N/A
  • WENN N/A
  • Revenue Growth
  • XOMA 194.98
  • WENN N/A
  • 52 Week Low
  • XOMA $18.35
  • WENN $9.67
  • 52 Week High
  • XOMA $39.92
  • WENN $10.40
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 45.06
  • WENN N/A
  • Support Level
  • XOMA $34.25
  • WENN N/A
  • Resistance Level
  • XOMA $39.00
  • WENN N/A
  • Average True Range (ATR)
  • XOMA 2.00
  • WENN 0.00
  • MACD
  • XOMA -0.56
  • WENN 0.00
  • Stochastic Oscillator
  • XOMA 11.11
  • WENN 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About WENN Wen Acquisition Corp Class A Ordinary Shares

Wen Acquisition Corp is a blank check company.

Share on Social Networks: